N-Pyrrylarylsulfones with High Therapeutic Potential

被引:7
作者
Famiglini, Valeria [1 ]
Castellano, Sabrina [2 ]
Silvestri, Romano [1 ]
机构
[1] Sapienza Univ Rome, Dept Drug Chem & Technol, Lab Ist Pasteur Italia Fdn Cenci Bolognetti, Piazzale Aldo Moro 5, I-00185 Rome, Italy
[2] Univ Salerno, Dept Pharm, Via Giovanni Paolo II 132, I-84084 Salerno, Italy
来源
MOLECULES | 2017年 / 22卷 / 03期
关键词
sulfonamide; heterocycle; polycyclic compound; therapeutic agent; REVERSE-TRANSCRIPTASE INHIBITORS; INDOLYL ARYL SULFONES; BENZOTHIADIAZEPINE MOIETY; BIOLOGICAL EVALUATION; NONNUCLEOSIDE INHIBITOR; SELECTIVE-INHIBITION; SMILES REARRANGEMENT; CHEMICAL FORMULAS; WILD-TYPE; DERIVATIVES;
D O I
10.3390/molecules22030434
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
This review illustrates the various studies made to investigate the activity of N-pyrrylarylsulfone containing compounds as potential antiviral, anticancer and SNC drugs. A number of synthetic approaches to obtain tetracyclic, tricyclic and non-cyclic compounds, and their biological activity with regard to structure-activity relationships (SARs) have been reviewed. The literature reviewed here may provide useful information on the potential of N-pyrrylarylsulfone pharmacophore as well as suggest concepts for the design and synthesis of new N-pyrrylarylsulfone based agents.
引用
收藏
页数:18
相关论文
共 80 条
  • [1] Estimation and application of biological variation of urinary δ-aminolevulinic acid and porphobilinogen in healthy individuals and in patients with acute intermittent porphyria
    Aarsand, AK
    Petersen, PH
    Sandberg, S
    [J]. CLINICAL CHEMISTRY, 2006, 52 (04) : 650 - 656
  • [2] 5H-Pyrrolo[1,2-b][1,2,5]benzothiadiazepines (PBTDs): A novel class of non-nucleoside reverse transcriptase inhibitors
    Artico, M
    Silvestri, R
    Pagnozzi, E
    Stefancich, G
    Massa, S
    Loi, AG
    Putzolu, M
    Corrias, S
    Spiga, MG
    LaColla, P
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY, 1996, 4 (06) : 837 - 850
  • [3] SYNTHESIS OF PYRRYL ARYL SULFONES TARGETED AT THE HIV-1 REVERSE-TRANSCRIPTASE
    ARTICO, M
    SILVESTRI, R
    STEFANCICH, G
    MASSA, S
    SCINTU, F
    PAGNOZZI, E
    MASU, D
    PINNA, E
    TINTI, E
    LACOLLA, P
    [J]. ARCHIV DER PHARMAZIE, 1995, 328 (03) : 223 - 229
  • [4] Structure-based design, synthesis, and biological evaluation of navel pyrrolyl aryl sulfones: HIV-1 non-nucleoside reverse transcriptase inhibitors active at nanomolar concentrations
    Artico, M
    Silvestri, R
    Pagnozzi, E
    Bruno, B
    Novellino, E
    Greco, G
    Massa, S
    Ettorre, A
    Loi, AG
    Scintu, F
    La Colla, P
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2000, 43 (09) : 1886 - 1891
  • [5] 2-Sulfonyl-4-chloroanilino moiety: A potent pharmacophore for the anti-human immunodeficiency virus type 1 activity of pyrrolyl aryl sulfones
    Artico, M
    Silvestri, R
    Massa, S
    Loi, AG
    Corrias, S
    Piras, G
    LaColla, P
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1996, 39 (02) : 522 - 530
  • [6] HETEROCYCLES WITH A BENZOTHIADIAZEPINE MOIETY .1. SYNTHESIS OF PYRROLO[1,2-B]-SYM-TRIAZOLO[3,4-D][1,2,5]BENZOTHIADIAZEPINE 5,5-DIOXIDE
    ARTICO, M
    SILVESTRI, R
    STEFANCICH, G
    [J]. SYNTHETIC COMMUNICATIONS, 1992, 22 (10) : 1433 - 1439
  • [7] ARTICO M, 1994, MED CHEM RES, V4, P283
  • [8] Potent and selective inhibition of human immunodeficiency virus type 1 transcription by piperazinyloxoquinoline derivatives
    Baba, M
    Okamoto, M
    Makino, M
    Kimura, Y
    Ikeuchi, T
    Sakaguchi, T
    Okamoto, T
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1997, 41 (06) : 1250 - 1255
  • [9] BANDMANN HJ, 1973, BRIT J DERMATOL, V89, P219
  • [10] Pyrrole: a resourceful small molecule in key medicinal hetero-aromatics
    Bhardwaj, Varun
    Gumber, Divya
    Abbot, Vikrant
    Dhiman, Saurabh
    Sharma, Poonam
    [J]. RSC ADVANCES, 2015, 5 (20): : 15233 - 15266